Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance

Abstract

BackgroundTumor cells in chronic lymphocytic leukemia accumulate in the periphery through the proliferation of a minority of cells in lymph nodes. The proliferative and survival signals in these proliferation centers include interactions with T lymphocytes expressing CD40 ligand. We have demonstrated that the low toxicity combination of bezafibrate and medroxyprogesterone acetate induces mitochondrial superoxide-mediated apoptosis of non-CD40-liganded cells but not of cells exposed to CD40 ligand. Here, we assessed the ability of dasatinib and lycorine to restore bezafibrate-and medroxyprogesterone acetate-induced apoptosis in cells exposed to CD40 ligand. In parallel experiments we compared the ability of dasatinib to induce apoptosis of cells co-treated with fludarabine. Design and MethodsPrimary chronic lymphocytic leukemia and peripheral blood mononuclear cells were exposed to drug combinations for 72 hours on control and CD40 ligand-expressing fibroblast monolayers. Cells were harvested and analyzed for apoptosis and levels of mitochondrial superoxide using flow cytometry. In some experiments cells were removed from CD40 ligand at 48 hours, retreated and analyzed after a further 24 hours. The effect of CD40 ligand and drug treatments on mitochondrial superoxide levels were assessed. ResultsAs previously described, dasatinib rendered cells sensitive to fludarabine but only when CD40 ligand was removed for the last 24 hours of culture. In contrast, lycorine restored the bezafibrate-and medroxyprogesterone acetate-induced apoptosis associated with mitochondrial superoxide even during continuous exposure to CD40 ligand. Furthermore, combined bezafibrate, medroxyprogesterone acetate and lycorine had little effect against normal peripheral blood mononuclear cells, whereas dasatinib with fludarabine induced high levels of apoptosis. ConclusionsOur data indicate the potential of bezafibrate, medroxyprogesterone acetate and lycorine as novel therapy in chronic lymphocytic leukemia and have important implications for the reported potential of c-abl kinase inhibitors in this disease.Key words: bezafibrate, medroxyprogesterone acetate, lycorine, chronic lymphocytic leukemia, mitochondrial superoxide, CD40 ligand. CD40-mediated drug resistance. Haematologica 2010;95(11):1889-1896. doi:10.3324/haematol.2010 This is an open-access paper. Citation: Hayden RE, Pratt G, Drayson MT, and Bunce CM. Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate-and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reportedLycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate-and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance

Histological Characteristics of Thymus Assessed with Stereological Parameters after Medroxyprogesterone Acetate Application

“…The most recent investigations have confirmed previous knowledge that MPA provokes apoptotic changes of T lymphocytes in the lymph nodes [18]. Despite multiple contradictory experimental studies, clinical observations suggest that MPA inhibits CD8 + T cell viral specific effector function and induces herpes simplex virus type 1 reactivation.…”

Bezafibrate and medroxyprogesterone acetate target resting and CD40L-stimulated primary marginal zone lymphoma and show promise in indolent B-cell non-Hodgkin lymphomas

“…For the majority of samples this was unlikely to be a factor, owing to the high proportion of B cells present. However, to address this, samples where B cell proportions were lower were co-stained with anti-CD 19 along with Previously we have shown that the anti-leukemic activity of BEZ and MPA involves deregulation of mitochondrial func tion [27,30]; in particular in CLL we observed that the gen eration of MSO [25,27] was central to the apoptotic action of the drugs. In contrast the anti-leukemic action of BEZ, MPA and BEZ + MPA on proliferation occurred without generat ing MSO [5].…”

“…Patients had p ro vided informed written consent for the study, which had received local ethical approval. Primary m ononuclear cells were prepared using Ficoll Paque-Plus (Anachem) as previously described [25], …”

Towards a Molecular Understanding of the Biosynthesis of Amaryllidaceae Alkaloids in Support of Their Expanding Medical Use

“…Most notably, several Amaryllidaceae alkaloids are being evaluated as anti-cancer drugs [12]. Lycorine is a powerful inhibitor of ascorbic acid biosynthesis, and also a powerful inhibitor of cell growth and cell division, including antitumor activity in animal and human cell lines [58,59]. Other alkaloids of this type, such as caranine, galanthine, pseudolycorine and 2- O -acetylpseudolycorine, are also active against a variety of tumour cells.…”